|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
510837395 |
| 003 |
DE-627 |
| 005 |
20230905073255.0 |
| 007 |
tu |
| 008 |
060425s2006 fr ||||| 00| ||eng c |
| 020 |
|
|
|a 9264014039
|9 92-64-01403-9
|
| 028 |
5 |
2 |
|a 93 2006 01 1 P
|
| 035 |
|
|
|a (DE-627)510837395
|
| 035 |
|
|
|a (DE-576)283524367
|
| 035 |
|
|
|a (DE-599)GBV510837395
|
| 035 |
|
|
|a (OCoLC)255121525
|
| 035 |
|
|
|a (OCoLC)255121525
|
| 035 |
|
|
|a (AT-OBV)AC05263667
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|a fre
|
| 044 |
|
|
|c XA-FR
|c XP
|
| 050 |
|
0 |
|a RS380
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a QR 525
|q OBV
|2 rvk
|0 (DE-625)rvk/142044:
|
| 084 |
|
|
|a 58.28
|2 bkl
|
| 084 |
|
|
|a 58.30
|2 bkl
|
| 245 |
1 |
0 |
|a Innovation in pharmaceutical biotechnology
|b comparing national innovation systems at the sectoral level
|c Organisation for Economic Co-operation and Development
|
| 264 |
|
1 |
|a Paris
|b OECD
|c 2006
|
| 300 |
|
|
|a 187 S.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Literaturangaben
|
| 500 |
|
|
|a Zsfassung in franz. Sprache
|
| 500 |
|
|
|a Parallel als Online-Ausg. erschienen
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
| 650 |
|
7 |
|8 1.1\x
|a Innovation
|0 (DE-627)091367840
|0 (DE-2867)10459-1
|2 stw
|
| 650 |
|
7 |
|8 1.2\x
|a Technologiepolitik
|0 (DE-627)091360765
|0 (DE-2867)10437-4
|2 stw
|
| 650 |
|
7 |
|8 1.3\x
|a Biotechnologie
|0 (DE-627)091352266
|0 (DE-2867)15635-3
|2 stw
|
| 650 |
|
7 |
|8 1.4\x
|a Gentechnisch erzeugtes Produkt
|0 (DE-627)091352258
|0 (DE-2867)14722-6
|2 stw
|
| 650 |
|
7 |
|8 1.5\x
|a Belgien
|0 (DE-627)091350212
|0 (DE-2867)17201-5
|2 stw
|
| 650 |
|
7 |
|8 1.6\x
|a Finnland
|0 (DE-627)091360080
|0 (DE-2867)16982-5
|2 stw
|
| 650 |
|
7 |
|8 1.7\x
|a Frankreich
|0 (DE-627)091361060
|0 (DE-2867)17255-3
|2 stw
|
| 650 |
|
7 |
|8 1.8\x
|a Deutschland
|0 (DE-627)091354749
|0 (DE-2867)18012-3
|2 stw
|
| 650 |
|
7 |
|8 1.9\x
|a Japan
|0 (DE-627)091369282
|0 (DE-2867)17568-3
|2 stw
|
| 650 |
|
7 |
|8 1.10\x
|a Niederlande
|0 (DE-627)091380170
|0 (DE-2867)17433-5
|2 stw
|
| 650 |
|
7 |
|8 1.11\x
|a Norwegen
|0 (DE-627)091380502
|0 (DE-2867)16985-6
|2 stw
|
| 650 |
|
7 |
|8 1.12\x
|a Spanien
|0 (DE-627)091390672
|0 (DE-2867)17161-5
|2 stw
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology
|x Technological innovations
|
| 650 |
|
0 |
|a Biotechnology
|x Research
|
| 650 |
|
2 |
|a Biomedical Technology
|
| 650 |
|
2 |
|a Biotechnology
|
| 650 |
|
2 |
|a Research
|
| 650 |
|
2 |
|a Technology, Pharmaceutical
|
| 689 |
0 |
0 |
|D b
|0 (DE-588)5157-3
|0 (DE-627)10014599X
|0 (DE-576)190169540
|a OECD
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4006890-0
|0 (DE-627)106375784
|0 (DE-576)208867643
|a Biopharmazie
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4026860-3
|0 (DE-627)106286757
|0 (DE-576)208968318
|a Industriepolitik
|2 gnd
|
| 689 |
0 |
3 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
| 689 |
0 |
4 |
|D s
|0 (DE-588)4114020-5
|0 (DE-627)105825220
|0 (DE-576)209481250
|a Innovationsförderung
|2 gnd
|
| 689 |
0 |
5 |
|D s
|0 (DE-588)4184587-0
|0 (DE-627)105293962
|0 (DE-576)210026774
|a Technologiepolitik
|2 gnd
|
| 689 |
0 |
|
|5 DE-101
|
| 689 |
1 |
0 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
| 689 |
1 |
1 |
|D s
|0 (DE-588)4069491-4
|0 (DE-627)104642904
|0 (DE-576)209176938
|a Biotechnologie
|2 gnd
|
| 689 |
1 |
2 |
|D s
|0 (DE-588)4027089-0
|0 (DE-627)106286102
|0 (DE-576)208969136
|a Innovation
|2 gnd
|
| 689 |
1 |
3 |
|D s
|0 (DE-588)7689632-8
|0 (DE-627)618407677
|0 (DE-576)318506688
|a Biologika
|2 gnd
|
| 689 |
1 |
|
|5 (DE-627)
|
| 710 |
2 |
|
|a OECD
|0 (DE-588)5157-3
|0 (DE-627)10014599X
|0 (DE-576)190169540
|4 oth
|
| 710 |
2 |
|
|a OECD
|0 (DE-588)5157-3
|0 (DE-627)10014599X
|0 (DE-576)190169540
|4 oth
|
| 776 |
0 |
8 |
|i Online-Ausg.
|t Innovation in Pharmaceutical Biotechnology
|d Paris : OECD Publishing, 2006
|h Online-Ressource (187 p.)
|w (DE-627)1648005039
|w (DE-576)308306007
|z 9789264014046
|
| 856 |
4 |
2 |
|u http://www.loc.gov/catdir/toc/fy0704/2006484250.html
|x Verlag
|y Table of contents only
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a ISIL_DE-1a
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a GBV_ILN_26
|
| 912 |
|
|
|a ISIL_DE-206
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a ISIL_DE-89
|
| 912 |
|
|
|a GBV_ILN_175
|
| 912 |
|
|
|a ISIL_DE-M158a
|
| 912 |
|
|
|a GBV_ILN_2014
|
| 912 |
|
|
|a ISIL_DE-90
|
| 935 |
|
|
|i Blocktest
|
| 936 |
r |
v |
|a QR 525
|b Chemikalien, Pharmazeutika. Kunststoffe. Keramik, Glas, Gummi
|k Wirtschaftswissenschaften
|k Gewerbepolitik. Einzelne Wirtschaftszweige
|k Industrie, Bergbau, Handel, Dienstleistungen, Handwerk
|k Verarbeitende Industrie
|k Chemikalien, Pharmazeutika. Kunststoffe. Keramik, Glas, Gummi
|0 (DE-627)1270876899
|0 (DE-625)rvk/142044:
|0 (DE-576)200876899
|
| 936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
| 936 |
b |
k |
|a 58.30
|j Biotechnologie
|0 (DE-627)106405365
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 11
|1 01
|x 0001
|b 766080102
|c 00
|f 2
|d 1 B 101690
|e u
|j --%%--
|y k
|z 22-09-06
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 775487554
|c 00
|f --%%--
|d 2860-2558
|e --%%--
|j --%%--
|y k
|z 18-09-06
|
| 980 |
|
|
|2 26
|1 01
|x 0206
|b 762581212
|c 00
|f K:
|d C 247551
|e u
|j --%%--
|y z1k
|z 15-05-06
|
| 980 |
|
|
|2 70
|1 01
|x 0089
|b 772804087
|c 00
|f Haus2
|d T 06 B 5232
|e u
|j --%%--
|y z
|z 26-07-06
|
| 980 |
|
|
|2 175
|1 01
|x 3285
|b 766969118
|c 00
|f --%%--
|d 06/92
|e i
|j --%%--
|h o
|y z
|z 31-05-06
|
| 980 |
|
|
|2 2014
|1 01
|x DE-90
|b 3179990775
|c 00
|f --%%--
|d 2014 E 679
|e --%%--
|j --%%--
|y l01
|z 15-10-14
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Innovation
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Innovationspolitik
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Biotechnologie
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Biotechnisches Produkt
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Belgien
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Finnland
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Deutschland
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Frankreich
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Niederlande
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Japan
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Niederlande
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Norwegen
|
| 982 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|a Spanien
|
| 982 |
|
|
|2 2014
|1 01
|x DE-90
|8 00
|s s
|a Biotechnologie
|
| 983 |
|
|
|2 26
|1 00
|x DE-206
|8 00
|a oe
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|0 (DE-627)299603717
|a O13
|b Economic development : agriculture; natural resources; environment; other primary products
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 00
|0 (DE-627)299603849
|a O31
|b Technological change : innovation and invention: processes and incentives
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EUBL
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EUFI
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EUGE
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EUFR
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 9JAPA
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EUNE
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EXNO
|
| 983 |
|
|
|2 175
|1 00
|x DE-M158a
|8 10
|a 4EUSP
|
| 984 |
|
|
|2 11
|1 01
|x 0001
|a 145562971010
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$028602558
|
| 984 |
|
|
|2 70
|1 01
|x 0089
|a 89$127084029
|
| 984 |
|
|
|2 175
|1 01
|x 3285
|a 158a$0335320
|
| 995 |
|
|
|2 175
|1 01
|x 3285
|a o
|
